Interleukin-2 or Observation Following Radiation Therapy, Combination Chemotherapy, and Peripheral Stem Cell Transplantation in Treating Patients With Recurrent Non-Hodgkin's Lymphoma

The requested reference [c9804f613a37778dc50fd8b73d99110f4a7e7206] no longer exists in our database. It has been replaced by the current reference: [28847d99c74d27bddc19cd39cd8978c59458d2b7]

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 1995
Randomized phase III trial to compare the effectiveness of interleukin-2 with that of observation following radiation therapy, combination chemotherapy, and peripheral stem cell transplantation in treating patients who have refractory or relapsed non-Hodgkin\'s lymphoma. Interleukin-2 may stimulate a person\'s white blood cells to kill non-Hodgkin\'s lymphoma cells. Giving interleukin-2 after radiation therapy, chemotherapy, and peripheral stem cell transplantation may kill more cancer cells
Epistemonikos ID: a3892528495d883cd5f3afe2a5d34de58322cf5e
First added on: May 03, 2024